Prognostic value of tumour vascularity in primary melanoma

Melanoma Research

Volumn 9, Issue 3, 1999, Pages 273-278

  Ilmonen, S ^a,c   Kariniemi, A L ^a   Vlaykova, T ^b   Muhonen, T ^a   Pyrhonen S ^b   Asko Seljavaara, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c NONE   (Finland)

Author keywords

Immunohistochemistry; Primary melanoma; Prognosis; Vascularity

Indexed keywords

ANGIOGENESIS; ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; SKIN CANCER; TUMOR BLOOD FLOW;

EID: 0032847303     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199906000-00009     Document Type: Article

References (29)

1. Breslow A. Thickness cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
2. Mooi W, Krausz T. Prognostic factors in cutaneous melanoma. In: Mooi E, Krausz T, eds. Biopsy Pathology of Melanocytic Disorders. 1992: 304-330.
3. Rigel D, Friedman R, Koff A, et al. Factors influencing survival in melanoma. Dermatol Clin 1991; 9: 631-642.
4. Woods J, Soule E, Creagan E. Metastasis and death in patients with thin melanomas (less than 0.76 mm). Ann Surg 1983: 63-64.
5. Paladugu P, Yonemoto R. Biologic behavior of thin malignant melanomas with regressive changes. Cancer 1983; 57: 545-548.
6. Naruns P, Nizze J, Corchran A, et al. Recurrence potential of thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1986; 42: 2282-2292.
7. Gromet M, Epstein W, Blois M. The regressing thin malignant melanoma. Cancer 1978; 42: 2282-2292.
8. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442-447.
9. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
10. Folkman J, Cotran R. Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976; 16: 207-248.
11. Craft PS, Harris AL. Clinical prognostic significance of tumor angiogenesis. Ann Oncol 1994; 5: 305-311.
12. Chodak GW, Haudenschild C, Gittes RF, et al. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann Surg 1980; 192: 762-771.
13. Gasparini G, Pozza F, Harris AL. Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 1993; 85: 1206-1219.
14. Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head and neck squamous cell carcinoma. Int J Cancer 1993; 55: 739-744.
15. Horak ER, Leek R, Klenk N, et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet 1992; 340: 1120-1124.
16. Toi M, Kashitani J, Tominaga T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 1993; 55: 371-371.
17. Wakui S, Furusato M, Itoh T, et al. Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992; 168: 262-275.
18. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
19. Weidner N, Carroll PR, Flax J, et al. Tumor angiogenesis correlates with metastasis in invasive prostatic carcinoma. Am J Pathol 1993; 143: 401-409.
20. Macchiarini P, Fontanini G, Hardin MJ, et al. Relation of neo-vascularization to metastasis of non-small-cell lung cancer. Lancet 1992; 340: 145-146.
21. Barnhill R, Fandrey K, Levy M, et al. Angiogenesis and tumor progression of melanoma. Lab Invest 1992; 67(3): 331-337.
22. Barnhill R, Mihm M Jr, Ceballos P. Angiogenesis and regressing cutaneous malignant melanoma. Lancet 1992; 339: 991-992.
23. Fallowfield M, Cook M. The vascularity of primary cutaneous melanoma. J Pathol 1991; 164: 241-244.
24. Srivastava A, Laidler P, Davies R, et al. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.9 mm thick) skin melanoma. Am J Pathol 1988; 133(2): 419-423.
25. Graham CH, Rivers J, Kerbel RS, et al. Extent of vascularization as a prognostic indicator in thin (less than 0.76 mm) malignant melanomas. Am J Pathol 1994; 145: 510-514.
26. Rongioletti F, Miracco C, Gambini C, et al. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. Am J Dermatopathol 1996; 18(5): 474-477.
27. Carnochan P, Briggs JC, Westbury G, et al. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. Br J Cancer 1991; 64: 102-107.
28. Barnhill R, Busam K, Berwick M, et al. Tumor vascularity is not a prognostic factor for cutaneous melanoma. Lancet 1994; 344(29): 1237-1238.
29. Busam KJ, Berwick M, Blessing K, et al. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. Am J Pathol 1995; 147(4): 1049-1056.